In addition, DPP4 also endogenously controls glycemia, which appears as an striking aspect, given that type 2 diabetes has been pointed out as the most important risk factor for SARS-CoV-2 infection and one of the main comorbidities of COVID-19. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.